Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00044-024-03342-9.

Title:
Targeting RNA-protein interactions with small molecules: promise and therapeutic potential | Medicinal Chemistry Research
Description:
The therapeutic potential of targeting protein-RNA interactions has not been fully explored. While several approaches to block the interactions between various RNA and protein partners have been developed, rational efforts to target pre-assembled complexes have not been broadly pursued. This is despite the recent commercial success of risdiplam, and the high-resolution structure of the EIF4A-polypurine-Rocaglamide A ternary complex, which elucidates how compounds may recognize these pockets. These prominent examples indicate the viability of this approach, but important questions remain. For example, how abundant are these pockets in other protein-RNA complexes? Do such pockets have properties suitable for small molecule recognition? A broad analysis of 160 previously published RNP complexes confirmed that interfacial pockets in RNA-protein complexes are both abundant and have favorable properties that would make them good candidates for rational screening campaigns. These conclusions are expected to have important implications especially for those working on developing small molecules that bind directly to RNA structural elements.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

pubmed, article, google, scholar, cas, rna, central, interactions, protein, pockets, small, rnaprotein, binding, molecules, targeting, chem, complex, proteinrna, cancer, complexes, rnabinding, proteins, interaction, rbps, biol, target, nat, cell, therapeutic, mol, discovery, structure, molecule, roca, httpsdoiorgs, med, interface, human, structures, methods, inhibitors, drug, translation, analysis, splicing, fig, compounds, rnp, rnas, smallmolecule,

Topics {✒️}

crispr-cas13-mediated peptide competition cap-binding antagonist bn7-gmp small-molecule-induced rna editing disease-causing protein-rna complexes rbp’eutics-rna-binding proteins double-stranded-rna-binding-motif /histone mrna stem-loop 7-benzylguanosine cap-analogue conjugates tumor-targeted nanoparticle delivery article download pdf stem-loop binding protein include mrna-protein interactions full size image ribosomal rna-protein interactions small-molecule inhibitors disrupt stress-inducible rnp granules stabilise protein–protein interactions developing rbp-targeted therapies stem-loop rna structure profile rna-protein interactions rna-binding protein hur protein-protein targeting field including small-molecule inhibitors strong pi-stacking interactions musashi rna-binding activity inducing protein-protein interactions rna-binding protein psf eif4a1-polypurine-rna tracks eif4a1-polypyrimidine rna tracks inhibits hur-rna interaction electrophilic α-chloroacetamide compound critical protein-rna interactions small molecule-rna targeting targeting protein-rna interactions targeting rna-protein interactions oncogenic fto demethylase inhibiting rbp-rna interactions messenger-rna-binding proteins small-molecule splicing modulator stable rna-protein complex lysine-targeted eif4e inhibitors pre-assembled rnp complex integrated multi-omics analysis stabilizing protein-rna complexes stabilizing rna-protein complexes pkr code-differential regulation lysine-reactive chemistry analyze protein-rna interactions msut2 rna-protein interaction rna-protein complexes provide

Questions {❓}

  • For example, how abundant are these pockets in other protein-RNA complexes?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Targeting RNA-protein interactions with small molecules: promise and therapeutic potential
         description:The therapeutic potential of targeting protein-RNA interactions has not been fully explored. While several approaches to block the interactions between various RNA and protein partners have been developed, rational efforts to target pre-assembled complexes have not been broadly pursued. This is despite the recent commercial success of risdiplam, and the high-resolution structure of the EIF4A-polypurine-Rocaglamide A ternary complex, which elucidates how compounds may recognize these pockets. These prominent examples indicate the viability of this approach, but important questions remain. For example, how abundant are these pockets in other protein-RNA complexes? Do such pockets have properties suitable for small molecule recognition? A broad analysis of 160 previously published RNP complexes confirmed that interfacial pockets in RNA-protein complexes are both abundant and have favorable properties that would make them good candidates for rational screening campaigns. These conclusions are expected to have important implications especially for those working on developing small molecules that bind directly to RNA structural elements.
         datePublished:2024-11-23T00:00:00Z
         dateModified:2024-11-23T00:00:00Z
         pageStart:2050
         pageEnd:2065
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s00044-024-03342-9
         keywords:
            RNA
            RNA-protein interactions
            Medicinal chemistry
            Chemical biology
            Pharmacology/Toxicology
            Biochemistry
            general
            Medicinal Chemistry
            Bioorganic Chemistry
            Inorganic Chemistry
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00044-024-03342-9/MediaObjects/44_2024_3342_Figa_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00044-024-03342-9/MediaObjects/44_2024_3342_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00044-024-03342-9/MediaObjects/44_2024_3342_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00044-024-03342-9/MediaObjects/44_2024_3342_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00044-024-03342-9/MediaObjects/44_2024_3342_Fig4_HTML.png
         isPartOf:
            name:Medicinal Chemistry Research
            issn:
               1554-8120
               1054-2523
            volumeNumber:33
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Curran Rhodes
               affiliation:
                     name:National Cancer Institute
                     address:
                        name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sumirtha Balaratnam
               affiliation:
                     name:National Cancer Institute
                     address:
                        name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kamyar Yazdani
               affiliation:
                     name:National Cancer Institute
                     address:
                        name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Srinath Seshadri
               affiliation:
                     name:National Cancer Institute
                     address:
                        name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John S. Schneekloth
               affiliation:
                     name:National Cancer Institute
                     address:
                        name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Targeting RNA-protein interactions with small molecules: promise and therapeutic potential
      description:The therapeutic potential of targeting protein-RNA interactions has not been fully explored. While several approaches to block the interactions between various RNA and protein partners have been developed, rational efforts to target pre-assembled complexes have not been broadly pursued. This is despite the recent commercial success of risdiplam, and the high-resolution structure of the EIF4A-polypurine-Rocaglamide A ternary complex, which elucidates how compounds may recognize these pockets. These prominent examples indicate the viability of this approach, but important questions remain. For example, how abundant are these pockets in other protein-RNA complexes? Do such pockets have properties suitable for small molecule recognition? A broad analysis of 160 previously published RNP complexes confirmed that interfacial pockets in RNA-protein complexes are both abundant and have favorable properties that would make them good candidates for rational screening campaigns. These conclusions are expected to have important implications especially for those working on developing small molecules that bind directly to RNA structural elements.
      datePublished:2024-11-23T00:00:00Z
      dateModified:2024-11-23T00:00:00Z
      pageStart:2050
      pageEnd:2065
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s00044-024-03342-9
      keywords:
         RNA
         RNA-protein interactions
         Medicinal chemistry
         Chemical biology
         Pharmacology/Toxicology
         Biochemistry
         general
         Medicinal Chemistry
         Bioorganic Chemistry
         Inorganic Chemistry
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00044-024-03342-9/MediaObjects/44_2024_3342_Figa_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00044-024-03342-9/MediaObjects/44_2024_3342_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00044-024-03342-9/MediaObjects/44_2024_3342_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00044-024-03342-9/MediaObjects/44_2024_3342_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00044-024-03342-9/MediaObjects/44_2024_3342_Fig4_HTML.png
      isPartOf:
         name:Medicinal Chemistry Research
         issn:
            1554-8120
            1054-2523
         volumeNumber:33
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Curran Rhodes
            affiliation:
                  name:National Cancer Institute
                  address:
                     name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sumirtha Balaratnam
            affiliation:
                  name:National Cancer Institute
                  address:
                     name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kamyar Yazdani
            affiliation:
                  name:National Cancer Institute
                  address:
                     name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Srinath Seshadri
            affiliation:
                  name:National Cancer Institute
                  address:
                     name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John S. Schneekloth
            affiliation:
                  name:National Cancer Institute
                  address:
                     name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Medicinal Chemistry Research
      issn:
         1554-8120
         1054-2523
      volumeNumber:33
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:National Cancer Institute
      address:
         name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
         type:PostalAddress
      name:National Cancer Institute
      address:
         name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
         type:PostalAddress
      name:National Cancer Institute
      address:
         name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
         type:PostalAddress
      name:National Cancer Institute
      address:
         name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
         type:PostalAddress
      name:National Cancer Institute
      address:
         name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Curran Rhodes
      affiliation:
            name:National Cancer Institute
            address:
               name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
               type:PostalAddress
            type:Organization
      name:Sumirtha Balaratnam
      affiliation:
            name:National Cancer Institute
            address:
               name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
               type:PostalAddress
            type:Organization
      name:Kamyar Yazdani
      affiliation:
            name:National Cancer Institute
            address:
               name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
               type:PostalAddress
            type:Organization
      name:Srinath Seshadri
      affiliation:
            name:National Cancer Institute
            address:
               name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
               type:PostalAddress
            type:Organization
      name:John S. Schneekloth
      affiliation:
            name:National Cancer Institute
            address:
               name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
      name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
      name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
      name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA
      name:Chemical Biology Laboratory, National Cancer Institute, Frederick, USA

External Links {🔗}(651)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.24s.